Polus

Polus is a South Korean biotechnology company specializing in the development and large-scale manufacturing of high-quality biosimilars. Founded by former executives from industry giants Celltrion and Samsung BioLogics, the company focuses on therapeutic proteins produced through microbial fermentation, such as insulin and human growth hormone. Polus aimed to disrupt the global biologics market by leveraging cost-efficient production at its large-scale facility in Hwaseong, South Korea. However, the company has faced significant financial challenges and liquidity crises in recent years, which have delayed its clinical programs and manufacturing operations. Despite these setbacks, Polus remains a notable player in the Korean biotech landscape due to its ambitious goal of providing affordable biologic medicines to global markets.